Kayoko Ryomoto

Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL

Yuichi Hattori, Masaaki Suzuki, Motoo Tsushima et al. · Atherosclerosis · 1998 · 124 citations

Life Sciences, Biochemistry, Risk Factor Analysis +12

High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study

Hiroyasu Mori, Akio Kuroda, Sumiko Yoshida et al. · Journal of Diabetes Investigation · 2020 · 87 citations · Full text

Medicine, Geriatric Medicine, Diabetology +14

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

Naoto Katakami, Tomoya Mita, Hidenori Yoshii et al. · Cardiovascular Diabetology · 2020 · 73 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

Naoto Katakami, Tomoya Mita, Hidenori Yoshii et al. · Cardiovascular Diabetology · 2021 · 58 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes

Naohiro Taya, Naoto Katakami, Tomoya Mita et al. · Cardiovascular Diabetology · 2021 · 36 citations · Full text

Medicine, Endocrinology, Internal Medicine +16